AACCE Investments
ScreenerStocksIndicesPicksETFsBlogPricing

© 2026 ACCE Investments. All rights reserved.

ACCE Investments - Institutional-grade stock research for retail investors | BetaList
IndicesStocksETFsScreenerBlogGlossaryCompareMarket dataAdvisors
TermsPrivacyCookiesDisclaimerLegal noticeProfessional termsAboutContact
AUGR.PA

Augros Cosmetic Packaging SA (AUGR.PA) fair value

Consumer Cyclical · Packaging & Containers · Euronext Paris · France
€4.80+0.00%
Market cap €7MUpdated Oct 24, 2026 · valuation updating
Our verdict
No fair value
We are missing the financial data our models need for this company. It will appear once the data arrives.
Not valued: the reporting and trading currencies cannot be matched reliably.
ACCE opinionAugros Cosmetic Packaging SA (AUGR.PA)
Fair value
Not available
ACCE price target
€3.60
Rating
Not rated
Horizon
12 months
ACCE price target published on 23 Oct 2026, 01:52 CEST.
Price used: €4.80 at the close on 22 Oct 2026, 17:30 CEST.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Full methodology
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
ACCE score
34
out of 100
1-year return
-29.9%
Dividend yield
0.00%

Augros Cosmetic Packaging SA in four questions

Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
OverviewAsk ACCEValuationQualityAnalystsSmart MoneyCompareNews and Record

Overview

ACCE thesis

Augros makes cosmetic packaging, the bottles, jars and closures that brands buy to put their creams and lotions in, and its 41.5% gross margin suggests it sells into the premium end of that market rather than commodity containers. Revenue grew 8.5%, which is respectable for a business this small, but operating margin of -17.8% and a return on equity of -447.6% show that the top line is not yet converting into profit or into equity value. At a 7 million euro market cap with no index membership, this is a micro-cap where liquidity and disclosure will limit any position, and the thesis rests on whether operating leverage can close the gap between a healthy gross margin and a loss-making operating line. The next thing to check is the cost base below gross profit and whether the 8.5% growth is coming from volume or price. If the numbers hold up, this is worth a deeper look, but the margin path is the question that decides it.

AI-assisted·How I use AIWritten Oct 23, 2026

Walk me through this stock

Plain-English pros, cons, and what to watch. Pro feature.

PRO

Ask ACCE

Valuation

INVESTOR
Where AUGR.PA's valuation models land
Price
€4.80
Create a free account: 5 full stock pages a month, no card.

See what each model says, the assumptions behind it, the bad, normal and good cases, and why the fair value changed.

Quality

INVESTOR
Quality and conviction INVESTOR FEATURE

The full quality picture: a reason under every score, how the scores moved, and the conviction breakdown.

  • +A plain reason under every score
  • +Conviction breakdown and growth / value / quality / momentum scores
  • +Score history: how each score moved over time

Analysts

Wall Street consensus

No analyst coverage yet.
Analyst intelligence INVESTOR FEATURE

The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.

  • +Price-target low / average / high vs the current price, with implied upside
  • +Forward revenue and EPS consensus by fiscal year
  • +ACCE fair-value models lined up against the Street

Smart Money

PRO

In one line

Trades are only made public after a delay. We show the delay so you know how old the news is.

Company insiders
No trades filed
Last 90 days
Congress
No trades filed
Last 180 days
Average delay
No trades filed
From trade to public filing
Do politicians beat the market? Our backtest →
Smart money tracking PRO FEATURE

Follow the informed money: 13F position changes, insider and Congress trades, and 13D activist filings.

  • +Quarter-over-quarter institutional position changes
  • +Every insider and Congress trade, with how late it was disclosed
  • +Active 13D activist filings and top holders

Compare

Where it sits vs peers

News and Record

Recent performance

1 week
-29.9%
1 month
-29.9%
3 months
-29.9%
6 months
-29.9%
YTD
-29.9%
1 year
-29.9%

Recommendation history, last 12 months

DateTypeNewPreviousPrice
23 Oct 2026, 01:52 CESTACCE price target€3.60first publication€4.80

This analysis is not personalised investment advice and does not take your situation, objectives or risk tolerance into account. ACCE Investments is not an authorised investment firm.

Investing in shares carries a risk of losing capital. The value of an investment can go down as well as up.

This security trades in EUR. Exchange-rate movements can increase or reduce the result in your own currency.

Valuation horizon: 12 months from the publication date.

Conflicts of interest. ACCE Investments is operated by Adrien Chantreuil, who may hold personal positions in the securities analysed. Positions are declared on each security. ACCE receives no payment from the companies analysed or from any intermediary for this analysis.

Get the full AUGR.PA page, free

Every model, the scenarios, fair value history, AI notes and the four questions. 5 full stock pages every month on the free plan, no card.

Free accounts get 5 full stock pages a month, including the full page.

Snapshot

Growth40Value37Quality25Momentum-Total34
Valuation
Trailing P/E
no data
Forward P/E
no data
PEG
0.00
P/B
11.17x
EV / Revenue
0.9x
Book value/sh
€-3.41
Enterprise value
€10M
Profitability
ROE
-447.6%
FCF yield
no data
ROIC
no data
Health and risk
Debt / equity
-0.84
Dividend yield
0.00%
Beta
-0.28

Price

No data · 1Y
No price history for 1Y

Ask anything about AUGR.PA

Answered from Augros Cosmetic Packaging SA fundamentals + recent valuations. Every number shows its source and date.

This stock Peer Peer median weaker → stronger
ROEbetter than 0% of peers
low -448%-448%high -5%
Div yieldbetter than 100% of peers
low 0.0%0.0%high 0.0%

Peers

Prices Oct 22, 2026
CompanyPriceFair valuevs fair valueP/EROEQualityScore
AUGR.PA Augros Cosmetic Packaging SA€4.80----447.6%2534
YHGJ Yunhong Green CTI Ltd. Common Stock$2.51----29.5%2620
BONG.ST Bong AB (publ)kr 0.32----7.4%3142
MGIH Millennium Group International Holdings Limited Ordinary Shares$1.32----26.3%3124
ALBI.PA Gascogne SA€2.08----4.9%3435
PACK Ranpak Holdings Corp Class A Common Stock$3.68----7.2%3032
ORBS Eightco Holdings Inc. Common Stock$0.76----157.3%3116

Sector report card

Where AUGR.PA ranks against its sector peers on each metric.

Computing percentiles…